newsfilter
← Latest News
GlobeNewswire·

Tvardi Therapeutics to Participate in Upcoming Investor Conferences

HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ:TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting